enGene Therapeutics Inc. (ENGNW) Operating income 2022–2025
enGene Therapeutics Inc. (ENGNW) annual operating income history from SEC filings — each fiscal year as reported.
-$123.2MFY2025 · since FY2022: -$19.4M → -$123.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$123.2M | -97.7% |
| FY2024 | -$62.3M | -139.1% |
| FY2023 | -$26.1M | -34.1% |
| FY2022 | -$19.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ENGNW financial trends
ENGNW RevenueENGNW Net incomeENGNW Net marginENGNW Gross profitENGNW Gross marginENGNW Operating marginENGNW Operating cash flowENGNW Free cash flowENGNW Capital expendituresENGNW Return on equityENGNW Stock buybacksENGNW Dividends paidENGNW Total assetsENGNW Total liabilitiesENGNW Shareholders’ equityENGNW overview →